Literature DB >> 10489109

Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia?

A E Barden1, L J Beilin, J Ritchie, B N Walters, C Michael.   

Abstract

OBJECTIVE: This study aimed to identify those factors in the non-pregnant state that distinguished women who developed pre-eclampsia from those who had normotensive pregnancies. DESIGN AND
SETTING: This was a retrospective analysis of anthropometry, blood pressure, biochemical and haematological variables in 62 women with pre-eclampsia and 84 normotensive pregnant women who took part in studies of the pathophysiology of pre-eclampsia. Pregnant volunteers were seen, after admission to hospital or in the outpatient clinic, and followed-up at 6 weeks and 6 months post-partum in the outpatient clinic or their home. Participants Proteinuric pre-eclampsia was defined as blood pressure > or = 140/90 mmHg with proteinuria of at least 300 mg/24 h after 20 weeks gestation, in women with no history of hypertension and whose blood pressure returned to normal levels by 6 months post-partum. Normotensive pregnancy was defined as blood pressure < 130/90 mmHg without proteinuria. MAIN OUTCOME MEASURES: The primary outcome measures were blood pressure, body mass index (BMI), triglycerides, total cholesterol, low density lipoprotein (LDL) and high density lipoprotein cholesterol and markers of severity of pre-eclampsia.
RESULTS: Regardless of parity, women with pre-eclampsia had elevated BMI before, during and after pregnancy compared with women who had normotensive pregnancies. Triglycerides were significantly elevated in women who had pre-eclampsia both before and after delivery, while total and LDL cholesterol were elevated significantly at both visits after delivery. Systolic and diastolic blood pressure, which by definition were elevated antepartum in women with pre-eclampsia, remained higher at post-partum visits compared with women who had normotensive pregnancies. Women with pre-eclampsia reported a greatly increased frequency of both maternal hypertension and pre-eclampsia. Markers of severity of pre-eclampsia, which normalized by 6 months postpartum, included plasma creatinine, uric acid, albumin, endothelin 1 and urinary protein, 2,3, dinor-6-keto-PGF1alpha, blood platelet and neutrophil counts.
CONCLUSION: The relative elevation of blood pressure, BMI and lipids in the non-pregnant state are features of the metabolic syndrome and may be important sensitizing factors contributing to the pathogenesis of pre-eclampsia. A familial predisposition to pre-eclampsia may operate partly through these mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489109     DOI: 10.1097/00004872-199917090-00011

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

Review 1.  Sex-related differences in the insulin resistance syndrome.

Authors:  D B Corry
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

3.  Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Authors:  Chahinda Ghossein-Doha; Marc Spaanderman; Sander M J van Kuijk; Abraham A Kroon; Tammo Delhaas; Louis Peeters
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

4.  Preconception cardiovascular risk factors and pregnancy outcome.

Authors:  Emily W Harville; Jorma S A Viikari; Olli T Raitakari
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

5.  Second trimester anti-angiogenic proteins and preeclampsia.

Authors:  Catherine L Haggerty; Michael E Seifert; Gong Tang; Jorn Olsen; Debra C Bass; S Ananth Karumanchi; Roberta B Ness
Journal:  Pregnancy Hypertens       Date:  2012-04-01       Impact factor: 2.899

6.  Pregnancy complications and later vascular ultrasound measures: A cohort study.

Authors:  Emily W Harville; Markus Juonala; Jorma S A Viikari; Mika Kähönen; Olli T Raitakari
Journal:  Pregnancy Hypertens       Date:  2017-08-04       Impact factor: 2.899

7.  Comparison of the resistive indices obtained in the uterine artery and the ophthalmic artery in preeclamptic and normotensive patients in Doppler US.

Authors:  Syeda Rabi Madina; Raham Bacha; Syed Amir Gilani; Wafa Fatima; Wahida Awais; Hamnah Fatima; Iqra Manzoor
Journal:  J Ultrason       Date:  2020-06-15

8.  A simple scoring method using cardiometabolic risk measurements in pregnancy to determine 10-year risk of type 2 diabetes in women with gestational diabetes.

Authors:  A Barden; R Singh; B Walters; M Phillips; L J Beilin
Journal:  Nutr Diabetes       Date:  2013-06-03       Impact factor: 5.097

Review 9.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.